论文部分内容阅读
目的研究妊娠高血压疾病孕妇血清8-iso-F2α、胱抑素C及CRP水平的变化与妊娠高血压疾病发生、发展的关系。方法选择妊娠高血压疾病患者56例及正常孕妇女56例检测其血清8-iso-F2α、胱抑素C及CRP水平。结果妊娠高血压疾病组血清8-iso-F2α、胱抑素C及CRP水平明显升高,与对照组相比,有显著差异(P<0.01);重度妊娠高血压疾病患者则明显高于中度和轻度妊娠高血压疾病患者组,差异有统计学意义(P<0.01)。结论动态监测血清中8-iso-F2α、胱抑素C、CRP水平有利于妊娠高血压疾病的预防及早期治疗,可以评价本病的病情发展及预后。
Objective To study the relationship between the changes of serum 8-iso-F2α, cystatin C and CRP levels and the occurrence and development of pregnancy-induced hypertension in pregnant women with gestational hypertension. Methods 56 cases of pregnancy-induced hypertension and 56 cases of normal pregnant women were selected to detect serum 8-iso-F2α, cystatin C and CRP levels. Results Serum levels of 8-iso-F2α, Cystatin C and CRP were significantly increased in patients with pregnancy-induced hypertension (P <0.01), while those in patients with severe pregnancy-induced hypertension were significantly higher than those in controls Degree and mild pregnancy-induced hypertension patients group, the difference was statistically significant (P <0.01). Conclusion The dynamic monitoring of serum 8-iso-F2α, Cystatin C and CRP levels is beneficial to the prevention and early treatment of pregnancy-induced hypertension. The disease progression and prognosis can be evaluated.